BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Biosimilars
Artificial intelligence
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Thursday, March 28, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Dec. 18, 2000
View Archived Issues
FDA clears new dose of Concerta for ADHD
Read More
Cytochroma collaborates with Johns Hopkins on vitamin D-related drug discovery
Read More
EntreMed commences phase I trial of Angiostatin by s.c. injection
Read More
Forest reports successful completion of phase III escitalopram clinical trial
Read More
Guilford seeks E.U. approval to begin trials of novel anesthetic and analgesic agents
Read More
British Biotech updates product development programs
Read More
First-in-class antithrombotic demonstrates benefits over comparators in preventing DVT
Read More
Amgen finalizes Kinetix acquisition
Read More
FDA approves pediatric indication for Tamiflu
Read More
Schering-Plough seeks additional FDA approval for Rebetol capsules
Read More
Another major merger announced
Read More
AeroGen begins phase II clinical trials with AeroDose insulin inhaler
Read More
Pharmacia returns rights to glaucoma diagnostic to InSite Vision
Read More
Anti-TNF-alpha MAb effective against spondyloarthropathy associated with Crohn's disease
Read More
Novel Yamanouchi compound activates gene expression, translocation of Glut4
Read More
Orally active HNE inhibitor in clinical trials at Ono
Read More
New antiretroviral Kaletra granted positive opinion in E.U.
Read More
Arzoxifene has identical effects to tamoxifen in endometrial cancer models
Read More
S-1 appears to safely improve survival in metastatic breast cancer patients
Read More
Nortran's phase II clinical trial of CP1 fails to meet primary endpoint
Read More
Potent MMP inhibitor delays osteolytic disease associated with breast cancer metastasis
Read More
Large group of MEK-inhibitory quinolines discovered at AstraZeneca
Read More
Inhibitors of Lp-PLA2 and their use in atherosclerosis described by SB in recent patent
Read More
Merck Frosst synthesizes potent, selective and orally active PDE4 inhibitors
Read More
Two series of inhibitors of alpha4beta1-mediated cell adhesion claimed by Aventis
Read More
Vitamin D-like effects discovered in novel Roche compounds
Read More
Dipeptide caspase, apoptosis inhibitors designed by Cytovia research team
Read More